Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
•
Prostate Cancer
Would you offer modest hypofractionation (e.g. 70 Gy/28 fractions) to a patient with intermediate risk prostate cancer and celiac disease?
Answer from: Radiation Oncologist at Community Practice
Celiac disease is primary small bowel disease. RT effect on rectum would not be exaggerated from the disease.
Sign in or Register to read more
5901
Related Questions
For a patient post-prostatectomy with a high PSA (>1), a negative MRI pelvis, and a negative PSMA PET scan, do you pursue any other imaging?
Would you consider re-irradiation for a prostate local failure for a patient who initially received standard fractionation with a focal SIB to 95 Gy, or a SBRT boost with cyberknife after EBRT?
In post-prostatectomy patients where urinary continence is never achieved, how and when would you plan RT when it is clinically indicated?
Which patients with prostate cancer do you consider to be good candidates for salvage local treatment after radiation therapy?
Under what circumstances would you treat prostate cancer without a biopsy?
Are there any contraindications to Pluvicto therapy you personally use, given that there are none directly provided by the manufacturer?
As PARTIQoL was a negative study, what is the current role for proton therapy in the management of prostate cancer patients?
How do you follow/manage patients with metastatic prostate cancer with undetectable PSA and castration-sensitive but active disease on PSMA PET?
How do you manage prostate cancer in patients that cannot swallow pills?
In what situations would a standard FDG PET/CT be useful in the evaluation of high risk prostate cancer?